drugset / Trial / NCT02293525

Clinical Evaluation of the ReLeaf Analgesic Infusion Catheter & Wound Drain

NCT02293525

Withdrawn Vital 5, LLC
RandomizedSingle-groupQuadruple-blindSupportive care

Summary

The purpose of this study is to evaluate the clinical performance of the ReLeaf infusion catheter \& wound drain in patients following lumbar spinal fusion surgery. One half of the patients will receive continuous local analgesic fusion during the post-operative period while the other half will received continuous local saline.

Timeline

Start
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ropivacaine Other / unclassified 0.2 %
Comparator Morphine Other / unclassified 1 mg
Comparator Oxycodone Other / unclassified 10 mg

Indications

No indication recorded.